Monday, May 15, 2017, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research ( Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market.

Headquartered in San Gabriel, California, CIIX offers a range of consulting services and educational tools for Chinese investors, but, most recently, it has been pursuing a presence in the growing cannabidiol (CBD) market. In line with these efforts, the company opened the first online CBD store in the Chinese language in the free trade area of Shanghai. It seeks to serve some 1.4 billion people. The site will sell hemp-based food and beverages and hemp-derived CBD. It seeks to sell, where legal, to Chinese-speaking consumers worldwide through its online store,

Consilium, an independent research company, notes in its report that the CBD industry is anticipated to grow to $2.1 billion by 2020, representing a CAGR of 80%. The research firm goes on to forecast that the sales of $14.8 million by FY2020 predicted for CIIX is achievable due to the company management’s ability to execute. In fact, Consilium feels that its projections could easily prove conservative. It also estimated that CIIX could reach sales of $1.86 million in FY2017, $3.7 million in FY2018 and $7.4 million in FY2019. CIIX reported revenues of $930,000 in FY2016. For the nine months ended February 28, 2017, it reported revenues of $1.35 million.

Consilium believes that CIIX has a strong management team that has entrepreneurial skills and vision. It also finds that the firm is engrained with Chinese speakers in both the U.S. and abroad. Weaknesses are that it may have to raise more money to compete. It will also need to have sufficient and appropriate resources to stay abreast of evolving requirements for legality in the U.S. and abroad, per the research report.

With no impediments cited by the report in terms of brand leaders, laws, or standouts in this nascent market, Consilium sees opportunities for growth for CIIX. These include strategic international expansion, the large size of the Chinese market and the successful leverage of the legal cannabis market, which Consilium anticipates will drive growth for years to come.

For more information, visit the company’s website at

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at

The Quality Stocks Daily Blog

The Quality Stocks Daily Videos

The Quality Stocks “Ones to Watch”

Please see disclaimer on the QualityStocks website:

No comments: